Advertisement

General Thoracic and Cardiovascular Surgery

, Volume 65, Issue 11, pp 633–639 | Cite as

Prognostic significance of neutrophil–lymphocyte ratios in large cell neuroendocrine carcinoma

  • Masayuki Okui
  • Takashi Yamamichi
  • Ayaka Asakawa
  • Masahiko Harada
  • Makoto Saito
  • Hirotoshi Horio
Original Article
  • 202 Downloads

Abstract

Objectives

Large cell neuroendocrine carcinomas (LCNECs) are rare neuroendocrine pulmonary malignancies with poor survival. Towards the goal of identifying a useful prognostic marker for LCNEC, we examined the prognostic significance of the neutrophil–lymphocyte ratio (NLR) in LCNEC patients after complete resection. The NLR is a potential predictive indicator in other cancers and can be easily determined at low cost.

Methods

We retrospectively reviewed the perioperative clinical and laboratory data of patients who underwent complete resection for LCNEC between 1995 and 2014. Correlations between the preoperative NLR and clinicopathological parameters were determined to assess its prognostic significance.

Results

Our study consisted of 26 patients, most of whom were men (88.5%) with a median age of 68.8 years. The median follow-up time was 54.4 months. Univariate analysis identified 3 clinically significant overall survival predictors: serum albumin level [≥4.0 g/dL (5-year overall survival rate; 80.0%) vs. <4.0 g/dL (30.0%), p = 0.048], pathological T stage [T1 and T2 (79.6%) vs. T3 and T4 (0%), p = 0.001], and preoperative NLR [<1.7 (90.9%) vs. ≥1.7 (51.7%), p = 0.012]. In a multivariate analysis, the NLR was an independent prognostic factor for overall survival (hazard ratio 8.559, 95% confidence interval 1.783–80.230, p = 0.011).

Conclusions

The preoperative NLR inversely correlates with post-resection survival rates in patients with LCNEC and thus is a viable prognostic marker in LCNEC.

Keywords

Neutrophil–lymphocyte ratio Large cell neuroendocrine carcinoma Lung cancer Inflammatory cells 

Notes

Compliance with ethical standards

Conflict of interest

The authors state that they have no conflicts of interest.

Supplementary material

11748_2017_804_MOESM1_ESM.tif (2.3 mb)
Supplementary material 1 (TIFF 2397 kb)
11748_2017_804_MOESM2_ESM.tif (2.3 mb)
Supplementary material 2 (TIFF 2312 kb)
11748_2017_804_MOESM3_ESM.xlsx (10 kb)
Supplementary material 3 (XLSX 10 kb)

References

  1. 1.
    Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB, Nieman L, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991;15:529–53.CrossRefPubMedGoogle Scholar
  2. 2.
    Dresler CM, Ritter JH, Patterson GA, Ross E, Bailey MS, Wick MR. Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg. 1997;63:180–5.CrossRefPubMedGoogle Scholar
  3. 3.
    Roesel C, Terjung S, Weinreich G, Gauler T, Theegarten D, Stamatis G, et al. A single-institution analysis of the surgical management of pulmonary large cell neuroendocrine carcinomas. Ann Thorac Surg. 2016;101:1909–14.CrossRefPubMedGoogle Scholar
  4. 4.
    Mallappa S, Sinha A, Gupta S, Chadwick SJD. Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis. 2013;15:323–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer. 2012;107:695–9.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137:425–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Travis W, Brambilla E, Mülller-Hermelink H, Harris C (Eds.). Tumours of the lung, pleura, thymus and heart. World Health Organization classification of tumours. Lyon: IARC Press; 2004Google Scholar
  8. 8.
    Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2:706–14.CrossRefPubMedGoogle Scholar
  9. 9.
    Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244–85.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001–5 (Japanease).PubMedGoogle Scholar
  11. 11.
    Migita K, Takayama T, Saeki K, Matsumoto S, Wakatsuki K, Enomoto K, et al. The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol. 2013;20:2647–54.CrossRefPubMedGoogle Scholar
  12. 12.
    Takahashi Y, Masafumi Kawamura B, Tai Hato B, Masahiko Harada B, Noriyuki Matsutani B, Hirotoshi Horio B. Neutrophil–lymphocyte ratio as a prognostic marker for lung adenocarcinoma after complete resection. World J Surg. 2016;40:365–72.CrossRefPubMedGoogle Scholar
  13. 13.
    Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–45.CrossRefPubMedGoogle Scholar
  14. 14.
    Kusumanto YH, Dam WA, Hospers GAP, Meijer C, Mulder NH. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis. 2003;6:283–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Lin EY, Pollard JW. Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer. 2004;90:2053–8.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    An X, Ding P-R, Li Y-H, Wang F-H, Shi Y-X, Wang Z-Q, et al. Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers. 2010;15:516–22.CrossRefPubMedGoogle Scholar
  17. 17.
    Yeun JY, Kaysen GA. Factors influencing serum albumin in dialysis patients. Am J Kidney Dis. 1998;32:S118–25.CrossRefPubMedGoogle Scholar
  18. 18.
    Lam PT, Leung MW, Tse CY. Identifying prognostic factors for survival in advanced cancer patients: a prospective study. Hong Kong Med J. 2007;13:453–9.PubMedGoogle Scholar
  19. 19.
    Barber MD, Ross JA, Fearon KC. Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer. 1999;35:106–10.CrossRefPubMedGoogle Scholar
  20. 20.
    Mori S, Usami N, Fukumoto K, Mizuno T, Kuroda H, Sakakura N, et al. The significance of the prognostic nutritional index in patients with completely resected non-small cell Lung cancer. PLoS One. 2015;10:e0136897.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Mazières J, Daste G, Molinier L, Berjaud J, Dahan M, Delsol M, et al. Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases. Lung Cancer. 2002;37:287–92.CrossRefPubMedGoogle Scholar
  22. 22.
    Rossi G, Cavazza A, Marchioni A, Longo L, Migaldi M, Sartori G, et al. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung. J Clin Oncol. 2005;23:8774–85.CrossRefPubMedGoogle Scholar
  23. 23.
    Iyoda A, Hiroshima K, Moriya Y, Takiguchi Y, Sekine Y, Shibuya K, et al. Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma. Ann Thorac Surg. 2006;82:1802–7.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Association for Thoracic Surgery 2017

Authors and Affiliations

  1. 1.Department of Thoracic SurgeryTokyo Metropolitan Cancer and Infectious Diseases Center Komagome HospitalTokyoJapan
  2. 2.Division of Clinical Research SupportTokyo Metropolitan Cancer and Infectious Diseases Center Komagome HospitalTokyoJapan

Personalised recommendations